{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:02:35Z","timestamp":1789941755365,"version":"4.0.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To develop a fully supervisable, monthly administered regimen for treatment of leprosy, the bactericidal effect of a single-dose combination of ofloxacin (OFLO) and minocycline (MINO), with or without rifampin (RMP), against\n            <jats:italic>Mycobacterium leprae<\/jats:italic>\n            was studied in the mouse footpad system and in previously untreated lepromatous leprosy patients. Bactericidal activity was measured by the proportional bactericidal method. In mouse experiments, the activity of a single dose of the combination OFLO-MINO was dosage related; the higher dosage of the combination displayed bactericidal activity which was significantly inferior to that of a single dose of RMP, whereas the lower dosage did not exhibit a bactericidal effect. In the clinical trial, 20 patients with previously untreated lepromatous leprosy were treated with a single dose consisting of either 600 mg of RMP plus 400 mg of OFLO and 100 mg of MINO or 400 mg of OFLO plus 100 mg of MINO. The OFLO-MINO combination exhibited definite bactericidal activity in 7 of 10 patients but was less bactericidal than the RMP-OFLO-MINO combination. Both combinations were well tolerated. Because of these promising results, a test of the efficacy of multiple doses of ROM in a larger clinical trial appears justified.\n          <\/jats:p>","DOI":"10.1128\/aac.42.5.1115","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:31:56Z","timestamp":1539045116000},"page":"1115-1120","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":28,"title":["Bactericidal Activity of a Single-Dose Combination of Ofloxacin plus Minocycline, with or without Rifampin, against\n            <i>Mycobacterium leprae<\/i>\n            in Mice and in Lepromatous Patients"],"prefix":"10.1128","volume":"42","author":[{"given":"Baohong","family":"Ji","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Faculte\u0301 de Me\u0301decine Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba","family":"Sow","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Institut Marchoux, Bamako, Mali2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Perani","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Faculte\u0301 de Me\u0301decine Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lienhardt","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Institut Marchoux, Bamako, Mali2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimala","family":"Diderot","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Faculte\u0301 de Me\u0301decine Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grosset","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Faculte\u0301 de Me\u0301decine Pitie\u0301-Salpe\u0302trie\u0300re, Paris, France,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.515"},{"key":"e_1_3_2_3_2","first-page":"7","article-title":"The \u201cproportional bactericidal test,\u201d a method for assessing bactericidal activity of drugs against Mycobacterium leprae in mice.","volume":"49","author":"Colston M. J.","year":"1978","unstructured":"Colston M. J. Hilson G. R. F. Bannerjee D. K. The \u201cproportional bactericidal test,\u201d a method for assessing bactericidal activity of drugs against Mycobacterium leprae in mice. Lepr. Rev. 49 1978 7 15","journal-title":"Lepr. Rev."},{"key":"e_1_3_2_4_2","first-page":"205","article-title":"Clofazimine and dapsone compliance in leprosy.","volume":"59","author":"Ellard G. A.","year":"1988","unstructured":"Ellard G. A. Pannikar V. K. Jesudasan K. Christian M. Clofazimine and dapsone compliance in leprosy. Lepr. Rev. 59 1988 205 223","journal-title":"Lepr. Rev."},{"key":"e_1_3_2_5_2","first-page":"8","article-title":"Minocycline in lepromatous leprosy.","volume":"63","author":"Fajardo T. T.","year":"1995","unstructured":"Fajardo T. T. Villahermosa L. G. dela Cruz E. C. Abalos R. M. Franzblau S. G. Walsh G. P. Minocycline in lepromatous leprosy. Int. J. Lepr. 63 1995 8 17","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.12.1758"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.2.229"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1651"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.1.236"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.304.6819.91","article-title":"A clinical trial of minocycline in lepromatous leprosy.","volume":"304","author":"Gelber R. H.","year":"1992","unstructured":"Gelber R. H. Fukuda K. Byrd S. Murray L. P. Siu P. Tsang M. Rea T. H. A clinical trial of minocycline in lepromatous leprosy. Br. Med. J. 304 1992 31 32","journal-title":"Br. Med. J."},{"key":"e_1_3_2_11_2","first-page":"568","article-title":"Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.","volume":"62","author":"Gelber R. H.","year":"1994","unstructured":"Gelber R. H. Murray L. P. Siu P. Tsang M. Rea T. H. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. Int. J. Lepr. 62 1994 568 573","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_12_2","first-page":"113","article-title":"Successful treatment of a lepromatous patient with clarithromycin.","volume":"63","author":"Gelber R. H.","year":"1995","unstructured":"Gelber R. H. Successful treatment of a lepromatous patient with clarithromycin. Int. J. Lepr. 63 1995 113 115","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_13_2","first-page":"259","article-title":"Activity of ofloxacin against Mycobacterium leprae in the mouse.","volume":"56","author":"Grosset J. H.","year":"1988","unstructured":"Grosset J. H. Guelpa-Lauras C. C. Perani E. G. Beoletto C. Activity of ofloxacin against Mycobacterium leprae in the mouse. Int. J. Lepr. 56 1988 259 264","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_14_2","first-page":"281","article-title":"Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.","volume":"58","author":"Grosset J. H.","year":"1990","unstructured":"Grosset J. H. Ji B. Guelpa-Lauras C. C. Perani E. G. N\u2019Deli L. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int. J. Lepr. 58 1990 281 295","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_15_2","first-page":"313","article-title":"Recent advances in the chemotherapy of leprosy.","volume":"61","author":"Ji B.","year":"1990","unstructured":"Ji B. Grosset J. H. Recent advances in the chemotherapy of leprosy. Lepr. Rev. 61 1990 313 329 (Editorial.)","journal-title":"Lepr. Rev."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.3.579"},{"key":"e_1_3_2_17_2","first-page":"556","article-title":"Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and\/or rifampicin against Mycobacterium leprae in mice.","volume":"60","author":"Ji B.","year":"1992","unstructured":"Ji B. Perani E. G. Petinon C. Grosset J. H. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and\/or rifampicin against Mycobacterium leprae in mice. Int. J. Lepr. 60 1992 556 561","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.1.188"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.662"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.393"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2137"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.9.1953"},{"key":"e_1_3_2_23_2","first-page":"183","article-title":"The bactericidal effect of rifampicin on M. leprae in man: (a) single doses of 600, 900, and 1200 mg; and (b) daily doses of 300 mg.","volume":"44","author":"Levy L.","year":"1976","unstructured":"Levy L. Shepard C. C. Fasal P. The bactericidal effect of rifampicin on M. leprae in man: (a) single doses of 600, 900, and 1200 mg; and (b) daily doses of 300 mg. Int. J. Lepr. 44 1976 183 187","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_24_2","first-page":"78","article-title":"A method for counting acid-fast bacilli.","volume":"36","author":"Shepard C. C.","year":"1968","unstructured":"Shepard C. C. McRae D. H. A method for counting acid-fast bacilli. Int. J. Lepr. 36 1968 78 82","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4269\/ajtmh.1972.21.446","article-title":"Rapid bactericidal effect of rifampin on Mycobacterium leprae.","volume":"21","author":"Shepard C. C.","year":"1972","unstructured":"Shepard C. C. Levy L. Fasal P. Rapid bactericidal effect of rifampin on Mycobacterium leprae. Am. J. Trop. Med. Hyg. 21 1972 446 449","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4269\/ajtmh.1974.23.1120","article-title":"Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae.","volume":"23","author":"Shepard C. C.","year":"1974","unstructured":"Shepard C. C. Levy L. Fasal P. Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae. Am. J. Trop. Med. Hyg. 23 1974 1120 1124","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_27_2","first-page":"96","article-title":"Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.","volume":"50","author":"Shepard C. C.","year":"1982","unstructured":"Shepard C. C. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae. Int. J. Lepr. 50 1982 96 101","journal-title":"Int. J. Lepr."},{"key":"e_1_3_2_28_2","first-page":"121","article-title":"Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy.","volume":"69","author":"Single-Lesion Multicentre Trial Group","year":"1997","unstructured":"Single-Lesion Multicentre Trial Group Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Indian J. Lepr. 69 1997 121 129","journal-title":"Indian J. Lepr."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0041-3879(91)90025-N","article-title":"Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.","volume":"72","author":"Truffot-Pernot C.","year":"1991","unstructured":"Truffot-Pernot C. Ji B. Grosset J. H. Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle 72 1991 57 64","journal-title":"Tubercle"},{"key":"e_1_3_2_30_2","unstructured":"WHO Study Group\n          Chemotherapy of leprosy for control programmes. Technical Report Series no. 675.\n          1982\n          World Health Organization\n          Geneva Switzerland"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.5.1115","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.5.1115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:01:49Z","timestamp":1645480909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.42.5.1115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1128\/AAC.42.5.1115"],"URL":"https:\/\/doi.org\/10.1128\/aac.42.5.1115","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"1997-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-03-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}